Just seeking some clarity ( my life's mission :--) . The similarities with AMRN are interesting . AMRN was trading at a low of around 84 c in late 2014 and at risk of being delisted . Baker Bros came in and funded the Co ( plus a loan shark deal with a small Pharma lending co ) ....and they completed the Outcome clinical trial . Drug worked and FDA approved ..stock hit $26 Dec 2019 then Co lost a patent challenge and the stock crashed to mid $6 's . That decision is currently being appealed